Invex Therapeutics (ASX: IXC) Share Price

IXC

$0.12▲+31.87%

$9.0MRank #1534 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$9.0M

Volume

16K

P/E Ratio

-3.15

EPS

-$0.0095

Dividend Yield

0.00%

52-Week High

$0.18

52-Week Low

$0.075

Beta

0.533

Invex Therapeutics (ASX: IXC) is an Australian-listed company in the Healthcare sector with a market capitalisation of $9.0M and the 1534th-largest security on the ASX by market capitalisation. The IXC share price is $0.12, up 31.87% today and up 34.83% over the past 12 months. Shares have traded between $0.075 and $0.18 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Invex Therapeutics reported revenue of $0 and a net loss of $715,582.

Charts

$0.12

24H Range

$0.11

$0.12

52-Week Range

$0.075

$0.18

About Invex Therapeutics Ltd

Invex Therapeutics Ltd is an Australian biopharmaceutical company dedicated to researching and developing innovative treatments for various neurological disorders. Their primary focus is Exenatide, a promising therapeutic agent aimed at neurological conditions linked to or resulting from elevated intracranial pressure, including idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. Exenatide has successfully advanced through Phase II clinical trials. The company was founded in 2019 and operates from Perth, Australia.

IPO Date

5 July 2019

CEO

Timothy Ryan Slate

Employees

Website

invextherapeutics.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-715,582
Total Assets	$4.7M
Total Debt	$0
Free Cash Flow	$-410,960
Return on Equity	-15.74%
Profit Margin	—
Operating Margin	—

IXC Frequently Asked Questions

What is the Invex Therapeutics (ASX: IXC) share price?

The IXC share price is $0.12, up 31.87% for the day, based on the latest available ASX market data.

What is Invex Therapeutics's market capitalisation?

Invex Therapeutics has a market capitalisation of $9.0M, making it the 1534th-largest security listed on the ASX.

Does Invex Therapeutics pay a dividend?

IXC does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Invex Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), IXC reported revenue of $0 and a net loss of $715,582.

How many IXC shares are on issue?

Invex Therapeutics has approximately 75,153,850 shares on issue, based on its market capitalisation of $9.0M and current share price.

What sector is Invex Therapeutics in?

Invex Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Invex Therapeutics list on the ASX?

Invex Therapeutics listed on the Australian Securities Exchange on 5 July 2019.

Latest News

Kalkine ASX Update: What Is Supporting Momentum in Invex Therapeutics (ASX: IXC)?

Kalkine12 June 2026

Kalkine ASX Update: What Is Supporting Momentum in Invex Therapeutics (ASX: IXC)? Kalkine

Invex Therapeutics (ASX: IXC) Retreats as Healthcare Stocks Face Volatility

Kalkine10 June 2026

Invex Therapeutics (ASX: IXC) Retreats as Healthcare Stocks Face Volatility Kalkine

Insights: Invex Therapeutics Ltd (ASX:IXC)

smallcaps.com.au30 Oct 2025

Insights: Invex Therapeutics Ltd (ASX:IXC) smallcaps.com.au

IXC:ASX Announcement - Deferral of Annual General Meeting - 20 Nov 2025

Market Index20 Nov 2025

IXC:ASX Announcement - Deferral of Annual General Meeting - 20 Nov 2025 Market Index

Top 4 Small-cap ASX Biotech Stocks

Investing News Network17 June 2025

Top 4 Small-cap ASX Biotech Stocks Investing News Network

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
MEMMemphasys Limited	$17.1M	$0.006	-1.59	0.00%	–+0.00%
ICRIntelicare Holdings Limited	$10.9M	$0.023	0.00	0.00%	▼-2.13%
VBSVectus Biosystems Limited	$7.2M	$0.135	-3.28	0.00%	–+0.00%
ACRAcrux Limited	$6.8M	$0.017	9.33	0.00%	▼-5.56%
BGTBio-Gene Technology Limited	$5.9M	$0.022	-1.25	0.00%	▲+10.00%
PERPercheron Therapeutics Limited	$4.5M	$0.004	-0.79	0.00%	▼-11.11%
ADRAdherium Limited	$3.9M	$0.002	-0.50	0.00%	–+0.00%
BITBiotron Limited	$3.3M	$0.002	-1.22	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.11	$0.12	$0.11	$0.12	16K	▲+31.87%
11 June 2026	$0.11	$0.11	$0.091	$0.091	30K	–+0.00%
10 June 2026	$0.11	$0.11	$0.091	$0.091	30K	▼-17.27%
9 June 2026	$0.11	$0.11	$0.11	$0.11	1.2K	–+0.00%
8 June 2026	$0.11	$0.11	$0.11	$0.11	1.2K	–+0.00%
5 June 2026	$0.11	$0.11	$0.11	$0.11	1.2K	–+0.00%
4 June 2026	$0.11	$0.11	$0.11	$0.11	30K	–+0.00%
3 June 2026	$0.11	$0.11	$0.11	$0.11	30K	–+0.00%
2 June 2026	$0.11	$0.11	$0.11	$0.11	30K	–+0.00%
1 June 2026	$0.11	$0.11	$0.11	$0.11	39K	–+0.00%
29 May 2026	$0.11	$0.11	$0.11	$0.11	41K	–+0.00%
28 May 2026	$0.11	$0.11	$0.11	$0.11	38K	–+0.00%
27 May 2026	$0.11	$0.11	$0.11	$0.11	38K	▼-8.33%
26 May 2026	$0.12	$0.12	$0.105	$0.12	176K	–+0.00%
25 May 2026	$0.12	$0.12	$0.12	$0.12	89K	–+0.00%
22 May 2026	$0.12	$0.12	$0.12	$0.12	81K	▲+9.09%
21 May 2026	$0.115	$0.115	$0.11	$0.11	37K	–+0.00%
20 May 2026	$0.115	$0.115	$0.11	$0.11	37K	–+0.00%
19 May 2026	$0.115	$0.115	$0.11	$0.11	37K	▼-4.35%
18 May 2026	$0.12	$0.12	$0.115	$0.115	35K	▼-8.00%
15 May 2026	$0.125	$0.125	$0.125	$0.125	49K	–+0.00%
14 May 2026	$0.125	$0.125	$0.125	$0.125	24K	–+0.00%
13 May 2026	$0.125	$0.125	$0.125	$0.125	11K	▼-3.85%
12 May 2026	$0.13	$0.13	$0.13	$0.13	1.3K	–+0.00%
11 May 2026	$0.13	$0.13	$0.13	$0.13	1.3K	–+0.00%
8 May 2026	$0.13	$0.13	$0.13	$0.13	7K	–+0.00%
7 May 2026	$0.13	$0.13	$0.13	$0.13	7K	–+0.00%
6 May 2026	$0.13	$0.13	$0.13	$0.13	7K	–+0.00%
5 May 2026	$0.13	$0.13	$0.13	$0.13	2K	–+0.00%
4 May 2026	$0.13	$0.13	$0.13	$0.13	2K	–+0.00%

About Invex Therapeutics Ltd

IPO Date

5 July 2019

CEO

Timothy Ryan Slate

Employees

Website

invextherapeutics.com

IXC Frequently Asked Questions

What is the Invex Therapeutics (ASX: IXC) share price?

The IXC share price is $0.12, up 31.87% for the day, based on the latest available ASX market data.

What is Invex Therapeutics's market capitalisation?

Invex Therapeutics has a market capitalisation of $9.0M, making it the 1534th-largest security listed on the ASX.

Does Invex Therapeutics pay a dividend?

IXC does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Invex Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), IXC reported revenue of $0 and a net loss of $715,582.

How many IXC shares are on issue?

Invex Therapeutics has approximately 75,153,850 shares on issue, based on its market capitalisation of $9.0M and current share price.

What sector is Invex Therapeutics in?

Invex Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Invex Therapeutics list on the ASX?

Invex Therapeutics listed on the Australian Securities Exchange on 5 July 2019.

Company

Market Cap

Price

P/E

Div Yield

1D Change

MEMMemphasys Limited

$17.1M

$0.006

-1.59

0.00%

–+0.00%

ICRIntelicare Holdings Limited

$10.9M

$0.023

0.00

0.00%

▼-2.13%

VBSVectus Biosystems Limited

$7.2M

$0.135

-3.28

0.00%

–+0.00%

ACRAcrux Limited

$6.8M

$0.017

9.33

0.00%

▼-5.56%

BGTBio-Gene Technology Limited

$5.9M

$0.022

-1.25

0.00%

▲+10.00%

PERPercheron Therapeutics Limited

$4.5M

$0.004

-0.79

0.00%

▼-11.11%

ADRAdherium Limited

$3.9M

$0.002

-0.50

0.00%

–+0.00%

BITBiotron Limited

$3.3M

$0.002

-1.22

0.00%

–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.11	$0.12	$0.11	$0.12	16K	▲+31.87%
11 June 2026	$0.11	$0.11	$0.091	$0.091	30K	–+0.00%
10 June 2026	$0.11	$0.11	$0.091	$0.091	30K	▼-17.27%
9 June 2026	$0.11	$0.11	$0.11	$0.11	1.2K	–+0.00%
8 June 2026	$0.11	$0.11	$0.11	$0.11	1.2K	–+0.00%
5 June 2026	$0.11	$0.11	$0.11	$0.11	1.2K	–+0.00%
4 June 2026	$0.11	$0.11	$0.11	$0.11	30K	–+0.00%
3 June 2026	$0.11	$0.11	$0.11	$0.11	30K	–+0.00%
2 June 2026	$0.11	$0.11	$0.11	$0.11	30K	–+0.00%
1 June 2026	$0.11	$0.11	$0.11	$0.11	39K	–+0.00%
29 May 2026	$0.11	$0.11	$0.11	$0.11	41K	–+0.00%
28 May 2026	$0.11	$0.11	$0.11	$0.11	38K	–+0.00%
27 May 2026	$0.11	$0.11	$0.11	$0.11	38K	▼-8.33%
26 May 2026	$0.12	$0.12	$0.105	$0.12	176K	–+0.00%
25 May 2026	$0.12	$0.12	$0.12	$0.12	89K	–+0.00%
22 May 2026	$0.12	$0.12	$0.12	$0.12	81K	▲+9.09%
21 May 2026	$0.115	$0.115	$0.11	$0.11	37K	–+0.00%
20 May 2026	$0.115	$0.115	$0.11	$0.11	37K	–+0.00%
19 May 2026	$0.115	$0.115	$0.11	$0.11	37K	▼-4.35%
18 May 2026	$0.12	$0.12	$0.115	$0.115	35K	▼-8.00%
15 May 2026	$0.125	$0.125	$0.125	$0.125	49K	–+0.00%
14 May 2026	$0.125	$0.125	$0.125	$0.125	24K	–+0.00%
13 May 2026	$0.125	$0.125	$0.125	$0.125	11K	▼-3.85%
12 May 2026	$0.13	$0.13	$0.13	$0.13	1.3K	–+0.00%
11 May 2026	$0.13	$0.13	$0.13	$0.13	1.3K	–+0.00%
8 May 2026	$0.13	$0.13	$0.13	$0.13	7K	–+0.00%
7 May 2026	$0.13	$0.13	$0.13	$0.13	7K	–+0.00%
6 May 2026	$0.13	$0.13	$0.13	$0.13	7K	–+0.00%
5 May 2026	$0.13	$0.13	$0.13	$0.13	2K	–+0.00%
4 May 2026	$0.13	$0.13	$0.13	$0.13	2K	–+0.00%